You don't trust studies that are conducted by pharmaceutical companies or dermatologists, and you don't trust the FDA approval process.
Are you going to hop on pyrilutamide if it is FDA approved for hair loss? It's a topical AR antagonist with a binding affinity strong enough to compete with DHT. Who knows what this will do to you if it goes systemic either immediately or slowly over time. The only studies you will have to base your decision on will either be conducted by large pharmaceutical companies or dermatologists. No one else has a financial incentive to study it.
Finasteride and Pyrilutamide are very different.
Finasteride is a 5-α-reductase inhibitor that works by decreasing production of DHT by 70%.
Pyrilutamide is an androgen receptor antagonist, that binds to HF's androgen receptors avoiding androgens doing so.
Also, I didn't say I don't trust any study, of course there are some studies from dermatologists etc that I consider, but definitely not the FDA and definitely not any study regardless of the size, quality or company that makes it seem like side effects on Finasteride are rare.
When studies make it seem like side effects on Finasteride are nothing to worry about and are almost negligible I just know it's BS.
Also, that is completely false to assume just because an entity has lots of money, it doesn't mean they can't be Bribed/corrupt by more money/financial incentive.
We see this in almost every country where some really big companies with a lot of money end up getting Bribed by the government and vice versa.
Financial incentives have always been the way the world works no matter the size and wealth of the entity.
I actually am more interested in Kintor because I know they would get approved first in China's regulatory body before it happens in the US.
Once Kintor Pharmaceuticals gets approved in China and works it will be really telling if the USA doesn't FDA approve it when it potentially works. Then it would become too obvious that the FDA is trying to slow down the process and stop high potential new drugs from entering the market.
They won't want that to happen so I'm glad there are dual trials happening in China as well.
Last edited: